IL1B and Atypical behavior: In vivo studies, quercetin is reported to improve aging-, or LPS-induced behavior disorders, inhibit microglia and astrocytes activation, as well as decrease IL-1β levels via elevating SIRT1 protein expression and suppressing NLRP3, cleaved-Caspase-1 protein production in the brain of mice (49–51).